Cargando…

The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking

BACKGROUND: Platelet microparticles (PMPs) are platelet-derived membrane vesicles involved in cardiovascular diseases and atherosclerosis. Chronic hepatitis C (CHC) is associated with increased atherosclerosis, but the effect of therapy on its atherogenic potential has not been adequately studied. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanellopoulou, Theoni, Alexopoulou, Alexandra, Kontopidou, Flora N., Konstantinides, Polydoros, Papatheodoridis, George V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805741/ https://www.ncbi.nlm.nih.gov/pubmed/27065733 http://dx.doi.org/10.20524/aog.2016.0013

Ejemplares similares

Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D
por: Konstantinides, Polydoros, et al.
Publicado: (2018)

Development of non-Hodgkin’s lymphoma in a patient with primary biliary cirrhosis: A case report and review of the literature
por: Kanellopoulou, Theoni, et al.
Publicado: (2011)

Chronic myelogenous leukemia and colon cancer: A causal relationship or coincidence?
por: Kanellopoulou, Theoni, et al.
Publicado: (2011)

Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals
por: Alexopoulou, Alexandra, et al.
Publicado: (2015)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
por: Varbobitis, Ioannis, et al.
Publicado: (2016)

Changes in serum transforming growth factor-β1 levels in chronic hepatitis C patients under antiviral therapy
por: Kotsiri, Ioanna, et al.
Publicado: (2016)

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
por: Chen, Yen-Chun, et al.
Publicado: (2022)

Sofosbuvir: a novel oral agent for chronic hepatitis C
por: Cholongitas, Evangelos, et al.
Publicado: (2014)

The Significance of Circulating Cell-Free DNA Markers in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
por: Papatheodoridi, Alkistis, et al.
Publicado: (2021)

Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study
por: Darema, Maria, et al.
Publicado: (2020)

Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
por: Gountas, Ilias, et al.
Publicado: (2019)

Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report
por: Alexopoulou, Alexandra, et al.
Publicado: (2019)

Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B
por: Laras, Andreas, et al.
Publicado: (2022)

Abdominal tuberculosis in a non-immunosuppressed patient
por: Kanellopoulou, Theoni, et al.
Publicado: (2011)

New Approaches to the Treatment of Chronic Hepatitis B
por: Alexopoulou, Alexandra, et al.
Publicado: (2020)

Polyphenols: Modulators of Platelet Function and Platelet Microparticle Generation?
por: Ed Nignpense, Borkwei, et al.
Publicado: (2019)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)

Platelet Microparticle Controversial Role in Cancer
por: Nazari, Mahnaz, et al.
Publicado: (2021)

Platelet-Derived Microparticles and Autoimmune Diseases
por: Li, Xiaoshuai, et al.
Publicado: (2023)

Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
por: Papatheodoridi, Margarita, et al.
Publicado: (2020)

Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
por: Hu, Qianghua, et al.
Publicado: (2016)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

The Impact of Host Metabolic Factors on Treatment Outcome in Chronic Hepatitis C
por: Savvoula, Savvidou, et al.
Publicado: (2012)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
por: Bousali, Maria, et al.
Publicado: (2021)

Routine Screening Method for Microparticles in Platelet Transfusions
por: Millar, Daniel, et al.
Publicado: (2018)

Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents
por: Chen, Yen-Chun, et al.
Publicado: (2020)

Breaking the Mold: Transcription Factors in the Anucleate Platelet and Platelet-Derived Microparticles
por: Lannan, Katie L., et al.
Publicado: (2015)

Liver-related effects of chronic hepatitis C antiviral treatment
por: Laursen, Tea L, et al.
Publicado: (2020)

Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming
por: Gharib, Ehsan, et al.
Publicado: (2023)

Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts
por: Lin, Kung-Hung, et al.
Publicado: (2012)

Black Sorghum Phenolic Extract Modulates Platelet Activation and Platelet Microparticle Release
por: Ed Nignpense, Borkwei, et al.
Publicado: (2020)

Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation
por: Karakousis, Nikolaos D., et al.
Publicado: (2023)

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)

Microparticles of Sericin-Dextran Conjugate for Improving the Solubility of Antiviral Drug
por: Chen, Shuqi, et al.
Publicado: (2023)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
por: Yoo, Eric R., et al.
Publicado: (2016)

Approaches to treating tuberculosis by encapsulating metal ions and anti-mycobacterial drugs utilizing nano- and microparticle technologies
por: Alzahabi, Khaled H., et al.
Publicado: (2020)

Significance of the (13)C-caffeine breath test for patients with cirrhosis
por: Konstantinou, Dimitrios, et al.
Publicado: (2014)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
por: Tamori, Akihiro, et al.
Publicado: (2016)

Use of antiviral therapy in patients with chronic hepatitis C
por: Dragomiretskaya, Natalia, et al.
Publicado: (2015)

Generation of Platelet Microparticles after Cryopreservation of Apheresis Platelet Concentrates Contributes to Hemostatic Activity
por: Eker, İbrahim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g41mhgg7cpcovf2d1bkaf9s3hf